This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Illumina Inc. (ILMN) slid 1.21% to $143.24 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.77% to 7,501.24 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
This was the stock's second consecutive day of losses.
Illumina Inc. closed 7.90% short of its 52-week high of $155.53, which the company achieved on January 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc. (LH) fell 0.16% to $254.02, Charles River Laboratories International Inc. (CRL) fell 2.29% to $159.12, and Quest Diagnostics Inc. (DGX) fell 1.52% to $187.94.
Trading volume (2.0 M) eclipsed its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-14-26 1723ET

ILMN

LABU

SBIO

Illumina Inc. (ILMN) shares fell 1.21% to $143.24 on Thursday, marking the second consecutive day of losses, despite a positive trading session for the overall market. The stock is currently 7.90% below its 52-week high of $155.53. In comparison, competitors Labcorp Holdings Inc. (LH), Charles River Laboratories (CRL), and Quest Diagnostics (DGX) also experienced declines. Trading volume for Illumina was 2.0 million, surpassing its 50-day average of 1.5 million.

MarketWatch Automated

Illumina

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

ALPS Medical Breakthrough

Labcorp

Charles River Laboratorie

Quest Diagnostics

S&P 500

Dow Jones Industrial Average

Factset Research

Illumina Inc. Stock Underperforms Thursday When Compared To Competitors